DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Gore ME, Griffin CL, Hancock B. et al.
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial.
Lancet 2010;
375: 641-648
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.